Return to study ST002082 main page
MB Sample ID: SA198202
Local Sample ID: | G3_PS-WHI-101_11-04-2018 |
Subject ID: | SU002166 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 47-89 years |
Gender: | Male and female |
Human Inclusion Criteria: | Patients with lung cancer |
Select appropriate tab below to view additional metadata details:
Collection:
Collection ID: | CO002159 |
Collection Summary: | The study was conducted at six sites (hospitals and hospices) in the North West of England (UK) from June 2016 to September 2018. Patients with lung cancer were recruited prospectively and multiple urine samples were collected up to three times a week while an inpatient. Ethical approval was provided by North Wales (West) Research Ethics Committee (REC reference 15/WA/0464). Research team members collected 20 mL of urine from participants in a universal container. For those participants with a urinary catheter, the urine was collected using a needle and syringe from the catheter port. The samples were stored on site in a locked freezer at −20°C. An anonymised record of the medication administered was collected. Collection protocol described previously by Coyle et al. (BMJ Open. 2016; 6(11) e011763. doi: 10.1136/bmjopen-2016-011763). |
Sample Type: | Urine |
Volumeoramount Collected: | 20 mL |
Storage Conditions: | -20℃ |